Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
72.14
-0.03 (-0.04%)
At close: Jan 31, 2025, 4:00 PM
72.20
+0.06 (0.08%)
After-hours: Jan 31, 2025, 5:00 PM EST
Hologic Revenue
In the fiscal year ending September 28, 2024, Hologic had annual revenue of $4.03B, down -0.00%. Hologic had revenue of $988.00M in the quarter ending September 28, 2024, with 4.52% growth.
Revenue (ttm)
$4.03B
Revenue Growth
-0.00%
P/S Ratio
4.22
Revenue / Employee
$576,581
Employees
6,990
Market Cap
16.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 28, 2024 | 4.03B | -100.00K | -0.00% |
Sep 30, 2023 | 4.03B | -832.40M | -17.12% |
Sep 24, 2022 | 4.86B | -769.50M | -13.66% |
Sep 25, 2021 | 5.63B | 1.86B | 49.14% |
Sep 26, 2020 | 3.78B | 409.10M | 12.15% |
Sep 28, 2019 | Pro | Pro | Pro |
Sep 29, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 24, 2016 | Pro | Pro | Pro |
Sep 26, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
HOLX News
- 11 days ago - New Report Reveals Alarming Decline in Women's Cancer Testing Worldwide - Business Wire
- 15 days ago - Hologic: Reasonably, But Not Compellingly Valued - Seeking Alpha
- 20 days ago - Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025 - Business Wire
- 25 days ago - Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 26 days ago - Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 - Business Wire
- 26 days ago - Hologic Completes Acquisition of Gynesonics, Inc. - Business Wire
- 6 weeks ago - Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC - Business Wire
- 7 weeks ago - Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines - Business Wire